Emerging data reveals that retatrutide, a novel medication, could represent a significant advance in body loss . This drug combines the properties of a GLP-1 analog and a GIP analog, potentially offering a greater outcome than existing therapies . Study research have revealed encouraging findings , including substantial reductions in body and adva